Rocket Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights
Rocket Pharmaceuticals Inc share price today is $4.23, up -5.69%. The stock opened at $4.41 against the previous close of $4.39, with an intraday high of $4.59 and low of $4.13.
Rocket Pharmaceuticals Inc Share Price Chart
Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals Inc Share Price Performance
Rocket Pharmaceuticals Inc Institutional Holdings
Rocket Pharmaceuticals Inc Market Status
Rocket Pharmaceuticals Inc Fundamentals
Market Cap 449.48 M
PB Ratio 1.6214
PE Ratio 0.0
Enterprise Value 285.42 M
Total Assets 330.45 M
Volume 11126377
Rocket Pharmaceuticals Inc Company Financials
About Rocket Pharmaceuticals Inc & investment objective
Company Information Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inheritable cardiac disorder that is characterized by a progressive loss of cardiac muscle mass, severe right ventricular dilation, dysplasia, fibrofatty replacement of the myocardium and a high propensity to arrhythmias and sudden death (RP-A601), which is in phase 1; and BAG3 Dilated Cardiomyopathy (BAG3-DCM), which is a form of cardiomyopathy and is characterized by progressive thinning of the walls of the heart, which is in preclinical stage. It also develops ex vivo lentiviral (LV) programs, which include programs for Leukocyte Adhesion Deficiency-I (LAD-I), a genetic disorder that causes the immune system to malfunction (RP-L201); Fanconi Anemia (FA), a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells (RP-L102); and Pyruvate Kinase Deficiency (PKD), a red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia (RP-L301). It has license agreements with Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red de Enfermedades Raras, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and Temple University. Rocket Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Cranbury, New Jersey.
Organisation Biotechnology
Employees 202
Industry Biotechnology
CEO Dr. Gaurav D. Shah M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Rocket Pharmaceuticals Inc FAQs
What is the share price of Rocket Pharmaceuticals Inc today?
The current share price of Rocket Pharmaceuticals Inc is $4.23.
Can I buy Rocket Pharmaceuticals Inc shares in India?
Yes, Indian investors can buy Rocket Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Rocket Pharmaceuticals Inc shares in India?
You can easily invest in Rocket Pharmaceuticals Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Rocket Pharmaceuticals Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Rocket Pharmaceuticals Inc.
Can I buy fractional shares of Rocket Pharmaceuticals Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Rocket Pharmaceuticals Inc?
Rocket Pharmaceuticals Inc has a market cap of $449.48 M.
In which sector does Rocket Pharmaceuticals Inc belong?
Rocket Pharmaceuticals Inc operates in the Biotechnology sector.
What documents are required to invest in Rocket Pharmaceuticals Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Rocket Pharmaceuticals Inc?
The PE ratio of Rocket Pharmaceuticals Inc is N/A and the PB ratio is 1.62.